Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Gynuity Health Projects

Status

Completed

Conditions

Termination of Pregnancy

Treatments

Drug: Mifepristone

Study type

Interventional

Funder types

Other

Identifiers

NCT00994734

1.2.3

Details and patient eligibility

About

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Enrollment

615 patients

Sex

Female

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Reproductive age women seeking abortion services.
Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
Participants must be eligible for medical abortion according to clinician and clinic standards.
In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.